GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Daiken Medical Co Ltd (TSE:7775) » Definitions » Cyclically Adjusted Revenue per Share

Daiken Medical Co (TSE:7775) Cyclically Adjusted Revenue per Share : 円309.37 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Daiken Medical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Daiken Medical Co's adjusted revenue per share for the three months ended in Dec. 2023 was 円89.863. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円309.37 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Daiken Medical Co's average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Daiken Medical Co was 3.50% per year. The lowest was 3.10% per year. And the median was 3.30% per year.

As of today (2024-05-22), Daiken Medical Co's current stock price is 円552.00. Daiken Medical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円309.37. Daiken Medical Co's Cyclically Adjusted PS Ratio of today is 1.78.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Daiken Medical Co was 3.37. The lowest was 1.50. And the median was 2.01.


Daiken Medical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Daiken Medical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiken Medical Co Cyclically Adjusted Revenue per Share Chart

Daiken Medical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 257.97 268.43 272.50 282.37 297.70

Daiken Medical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 295.40 297.70 301.73 306.15 309.37

Competitive Comparison of Daiken Medical Co's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Daiken Medical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiken Medical Co's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Daiken Medical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Daiken Medical Co's Cyclically Adjusted PS Ratio falls into.



Daiken Medical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Daiken Medical Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=89.863/106.8000*106.8000
=89.863

Current CPI (Dec. 2023) = 106.8000.

Daiken Medical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 62.785 95.700 70.067
201406 61.931 98.000 67.492
201409 68.081 98.500 73.818
201412 69.612 97.900 75.940
201503 65.932 97.900 71.926
201506 65.439 98.400 71.025
201509 68.969 98.500 74.781
201512 72.022 98.100 78.409
201603 68.713 97.900 74.960
201606 67.633 98.100 73.631
201609 71.590 98.000 78.018
201612 72.803 98.400 79.018
201703 67.740 98.100 73.748
201706 69.427 98.500 75.277
201709 72.098 98.800 77.936
201712 79.379 99.400 85.289
201803 65.469 99.200 70.485
201806 69.777 99.200 75.123
201809 70.730 99.900 75.615
201812 79.674 99.700 85.348
201903 66.635 99.700 71.380
201906 71.628 99.800 76.652
201909 76.274 100.100 81.379
201912 78.365 100.500 83.277
202003 70.424 100.300 74.988
202006 62.337 99.900 66.643
202009 68.941 99.900 73.703
202012 78.109 99.300 84.008
202103 64.284 99.900 68.724
202106 68.823 99.500 73.872
202109 73.414 100.100 78.328
202112 81.255 100.100 86.694
202203 73.794 101.100 77.954
202206 76.457 101.800 80.212
202209 78.611 103.100 81.432
202212 84.987 104.100 87.191
202303 78.001 104.400 79.794
202306 82.216 105.200 83.466
202309 85.726 106.200 86.210
202312 89.863 106.800 89.863

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Daiken Medical Co  (TSE:7775) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Daiken Medical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=552.00/309.37
=1.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Daiken Medical Co was 3.37. The lowest was 1.50. And the median was 2.01.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Daiken Medical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Daiken Medical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Daiken Medical Co (TSE:7775) Business Description

Traded in Other Exchanges
N/A
Address
3-6-1, Dosho-Machi, Chuo-Ku, Osaka, JPN, 541-0045
Daiken Medical Co Ltd manufactures and sells medical equipment. The product line includes - Coopdech syrinjector, Coopdech Syrinjector PCA device, Coopdech Balloonjector, Coopdech Endobronchial blocker tube, Coopdech double-lumen endobronchial tube, Fit fix suction container system, Wet disinfectant mat, and others.

Daiken Medical Co (TSE:7775) Headlines

No Headlines